CABA-201 manufactured from three independent healthy donors and one SLE donor produced expected increased levels of cytokines in response to their intended target cells, CD19+ Nalm6 cells, comparable to the levels of cytokines produced from similarly stimulated FMC63 CAR T cells. Here, CD19 is linked to systemic lupus erythematosus.